Risks of dementia and stroke in patients with hypertension using telmisartan or other renin‑angiotensin system inhibitors
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Chi-Hung Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Telmisartan, Hypertension, Stroke, Dementia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Biostatistical Consultation Center at Chang Gung Memorial Hospital, Chang Gung Memorial Hospital, National Science and Technology Council of Taiwan.
Themen: Demenz, Schlaganfall
Abstract (Originalsprache)
INTRODUCTION The aim of this study was to investigate the cognitive and cerebrovascular outcomes of patients with hypertension (HTN) receiving various renin‐angiotensin system (RAS) inhibitors. METHODS We further categorized 39,665 patients with HTN receiving long‐term RAS inhibitor therapy into (1) telmisartan, (2) non‐telmisartan angiotensin receptor blocker (NT‐ARB), and (3) angiotensin‐converting enzyme inhibitor groups. The main outcomes were a diagnosis of all dementias and the occurrence of all strokes during follow‐up. RESULTS The telmisartan group had the lowest risk of all dementias (telmisartan vs NT‐ARB: hazard ratio [HR]: 0.78; 95% confidence interval [CI]: 0.60 to 1.01; telmisartan vs angiotensin‐converting enzyme inhibitor: HR: 0.67; 95% CI: 0.48 to 0.94). The telmisartan group also had a lower risk of all strokes when compared to NT‐ARB (HR: 0.78; 95% CI: 0.61 to 0.99) in the time‐dependent cohort. DISCUSSION Use of telmisartan may be associated with marginally lower risks of all dementias and strokes compared to other RAS inhibitors in patients with HTN. Highlights Whether telmisartan is associated with a reduced risk of dementia compared to other RAS inhibitors in patients with HTN and varying blood sugar levels remains unclear. Our cohort study aimed to investigate the long‐term cognitive and cerebrovascular outcomes of hypertensive patients receiving telmisartan compared to those receiving other RAS inhibitors. Eligible individuals were categorized into three groups. Use of telmisartan may be associated with marginally lower risks of all dementia and stroke compared with other RAS inhibitors in patients with HTN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
- School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
- Institute of Health Policy and Management, College of Public Health, National Taiwan University, Taipei, Taiwan.
- Division of Cardiology, Department of Internal Medicine, New Taipei Municipal TuCheng Hospital, New Taipei, Taiwan.
- Division of Cardiology, Department of Internal Medicine and the Center of data science and Biostatistics, Keelung Chang Gung Memorial Hospital, Keelung City, Taiwan.
- School of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan City, Taiwan.
ORCID-Profile: Chi-Hung Liu, Yi-Chia Wei
Förderung
- Biostatistical Consultation Center at Chang Gung Memorial Hospital
- Chang Gung Memorial Hospital
- National Science and Technology Council of Taiwan
Zitieren
APA
Liu, C. H., Tsai, M. L., Yang, N. I., Chang, T. Y., Chen, T. H., & Wei, Y. C. (2026). Risks of dementia and stroke in patients with hypertension using telmisartan or other renin‑angiotensin system inhibitors. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71153
Vancouver
Liu CH, Tsai ML, Yang NI, Chang TY, Chen TH, Wei YC. Risks of dementia and stroke in patients with hypertension using telmisartan or other renin‑angiotensin system inhibitors. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71153
BibTeX
@article{Liu2026,
author = {Liu, Chi-Hung and Tsai, Ming-Lung and Yang, Ning-I and Chang, Ting-Yu and Chen, Tien-Hsing and Wei, Yi-Chia},
title = {Risks of dementia and stroke in patients with hypertension using telmisartan or other renin‑angiotensin system inhibitors},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71153}
}
EUVIMED